Katherine Bowdish
Director/Board Member chez ADOCIA
Profil
Katherine S.
Bowdish is the founder of Bird Rock Bio Sub, Inc. She currently holds the position of President, Chief Executive Officer & Director at PIC Therapeutics, Inc. since 2020 and Independent Director at Adocia SA since 2021.
Previously, she served as Vice Chairman at Warp Drive Bio, Inc., Director at MyoKardia, Inc., Director at Portal Instruments, Inc., Director at Thermalin, Inc., President, Director & Chief Scientific Officer at Permeon Biologics, Inc., President at Alexion Pharmaceuticals, Inc. in 2009, Chief Executive & Scientific Officer at Prolifaron, Inc., President at Alexion Antibody Technologies, Vice President-Global Research & Development at Sanofi España SA, and Vice President Global R&D and Head of Sunrise at Sanofi-Sunrise from 2013 to 2019.
She obtained her undergraduate degree from The College of William & Mary and her doctorate degree from Columbia University College of Physicians & Surgeons.
Postes actifs de Katherine Bowdish
| Sociétés | Poste | Début |
|---|---|---|
| ADOCIA | Director/Board Member | 21/05/2021 |
PIC Therapeutics, Inc.
 PIC Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology PIC Therapeutics, Inc. operates as a biotechnology company, which focuses on transforming the treatment of cancer though the selective modulation of oncogene translation. The company was founded by Richard Peters and Gerhard Wagner and is headquartered in Boston, MA. | Chief Executive Officer | 12/08/2020 |
Anciens postes connus de Katherine Bowdish
| Sociétés | Poste | Fin |
|---|---|---|
Sanofi-Sunrise
 Sanofi-Sunrise Investment ManagersFinance Sanofi-sunrise is a venture capital subsidiary of Sanofi-Aventis Groupe SA founded in 1900. The firm is headquartered in Cambridge, Massachusetts . | Private Equity Investor | 28/02/2019 |
Bird Rock Bio, Inc.
 Bird Rock Bio, Inc. BiotechnologyHealth Technology Bird Rock Bio, Inc. develops protein therapeutics. It focuses on the discovery and development of novel antibodies with upsized potential that represent to antibody therapeutics. The company was founded by Richard J. Ulevitch, Phyllis Ellen Whiteley and Katherine S. Bowdish in 2007 and is headquartered in La Jolla, CA. | Chief Executive Officer | 20/06/2011 |
Thermalin, Inc.
 Thermalin, Inc. Pharmaceuticals: MajorHealth Technology Thermalin, Inc. engages in the development of insulin products for patients with diabetes. It offers stabilized, ultra-rapid, and highly concentrated; no refrigeration basal and mix; glucose-responsive smart basal; and StampPump insulins. The company was founded by Michael A. Weiss, Bruce H. Frank, and Richard Berenson in 2010 and is headquartered in Cleveland, OH. | Director/Board Member | - |
Portal Instruments, Inc.
 Portal Instruments, Inc. Medical SpecialtiesHealth Technology Portal Instruments, Inc. operates as a medical device company that focuses on drug delivery systems. It manufactures jet injectors that deliver drugs through the skin without a needle at specific depths and volumes. The firm engages in developing and commercializing a needle-free platform technology to transform the delivery of medicines and improve the patient experience. The company was founded by Patrick A. Anquetil and Ian W. Hunter in 2012 and is headquartered in Cambridge, MA. | Director/Board Member | - |
Warp Drive Bio, Inc.
 Warp Drive Bio, Inc. Miscellaneous Commercial ServicesCommercial Services Warp Drive Bio, Inc. focused on proprietary genomic technology to discover drugs of natural origin. The firm deployed proprietary platforms Genome Mining and Small Molecule Assisted Receptor Targeting (SMART) to discover and develop novel molecules addressing new pharmacologic mechanisms. The company was founded by Gregory L. Verdine, George McDonald Church, and James A. Wells in 2012 and was headquartered in Cambridge, MA. | Director/Board Member | - |
Formation de Katherine Bowdish
| The College of William & Mary | Undergraduate Degree |
| Columbia University College of Physicians & Surgeons | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| ADOCIA | Health Technology |
| Entreprise privées | 12 |
|---|---|
Alexion Pharmaceuticals, Inc.
 Alexion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Alexion Pharmaceuticals, Inc. engages in the business of serving patients and families affected by rare diseases and devastating conditions through the discovery, development, and commercialization of life-changing medicines. The firm also focuses on the development of haematology, nephrology, neurology, metabolic disorders, cardiology, and ophthalmology. The company was founded by Joseph A. Madri, David W. Keiser, Stephen P. Squinto, and Leonard Bell in January 1992 and is headquartered in Boston, MA. | Health Technology |
MyoKardia, Inc.
 MyoKardia, Inc. Pharmaceuticals: MajorHealth Technology MyoKardia, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovery, commercialization, and development of therapies for the treatment of cardiovascular diseases. Its lead therapeutic candidate, Mavacamten, is an orally administered allosteric modulator of cardiac myosin being developed for the treatment of hypertrophic cardiomyopathy (HCM). The company was founded by James A. Spudich, Jonathan G. Seidman, Christine Seidman, and Leslie Leinwand on June 8, 2012 and is headquartered in South San Francisco, CA. | Health Technology |
Portal Instruments, Inc.
Portal Instruments, Inc. Medical SpecialtiesHealth Technology Portal Instruments, Inc. operates as a medical device company that focuses on drug delivery systems. It manufactures jet injectors that deliver drugs through the skin without a needle at specific depths and volumes. The firm engages in developing and commercializing a needle-free platform technology to transform the delivery of medicines and improve the patient experience. The company was founded by Patrick A. Anquetil and Ian W. Hunter in 2012 and is headquartered in Cambridge, MA. | Health Technology |
Prolifaron, Inc.
 Prolifaron, Inc. Medical SpecialtiesHealth Technology Part of AstraZeneca PLC, Prolifaron, Inc. is a private company that develops antibodies addressing multiple disease areas. The company is based in San Diego, CA. The company was founded by John Randolph Larson, Carlos F. Barbas. Prolifaron was acquired by Alexion Pharmaceuticals, Inc., part of AstraZeneca PLC from July 21, 2021 on September 25, 2000 for $41 million. | Health Technology |
Bird Rock Bio, Inc.
Bird Rock Bio, Inc. BiotechnologyHealth Technology Bird Rock Bio, Inc. develops protein therapeutics. It focuses on the discovery and development of novel antibodies with upsized potential that represent to antibody therapeutics. The company was founded by Richard J. Ulevitch, Phyllis Ellen Whiteley and Katherine S. Bowdish in 2007 and is headquartered in La Jolla, CA. | Health Technology |
Alexion Antibody Technologies
 Alexion Antibody Technologies Miscellaneous Commercial ServicesCommercial Services Alexion Antibody Technologies develops therapeutic antibodies to address multiple diseases. | Commercial Services |
| Sanofi España SA | |
Thermalin, Inc.
Thermalin, Inc. Pharmaceuticals: MajorHealth Technology Thermalin, Inc. engages in the development of insulin products for patients with diabetes. It offers stabilized, ultra-rapid, and highly concentrated; no refrigeration basal and mix; glucose-responsive smart basal; and StampPump insulins. The company was founded by Michael A. Weiss, Bruce H. Frank, and Richard Berenson in 2010 and is headquartered in Cleveland, OH. | Health Technology |
Permeon Biologics, Inc.
 Permeon Biologics, Inc. BiotechnologyHealth Technology Permeon Biologics, Inc. develops intracellular biotherapeutics platform to enhance drug delivery. Its intraphilin technology platform leverages research on remodeling the surfaces of proteins to permit cell penetration without losing their structure or activity; and enables functional proteins to replace or restore defective pathways inside cells that cause disease. The company was founded by Douglas G. Cole, David R. Liu, John W. Ripple, and Noubar B. Afeyan in 2008 and is headquartered in Cambridge, MA. | Health Technology |
Warp Drive Bio, Inc.
Warp Drive Bio, Inc. Miscellaneous Commercial ServicesCommercial Services Warp Drive Bio, Inc. focused on proprietary genomic technology to discover drugs of natural origin. The firm deployed proprietary platforms Genome Mining and Small Molecule Assisted Receptor Targeting (SMART) to discover and develop novel molecules addressing new pharmacologic mechanisms. The company was founded by Gregory L. Verdine, George McDonald Church, and James A. Wells in 2012 and was headquartered in Cambridge, MA. | Commercial Services |
Sanofi-Sunrise
Sanofi-Sunrise Investment ManagersFinance Sanofi-sunrise is a venture capital subsidiary of Sanofi-Aventis Groupe SA founded in 1900. The firm is headquartered in Cambridge, Massachusetts . | Finance |
PIC Therapeutics, Inc.
PIC Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology PIC Therapeutics, Inc. operates as a biotechnology company, which focuses on transforming the treatment of cancer though the selective modulation of oncogene translation. The company was founded by Richard Peters and Gerhard Wagner and is headquartered in Boston, MA. | Health Technology |
